Dividend Growth Stocks: Abbvie Inc. (ABBV) Dividend Stock Analysis

(via www.dividend-growth-stocks.com)

Abbvie Inc. is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis. Linked here is a detailed analysis and commentary...

Shared: 
Twitter: 0 LinkedIn: 0 Facebook: 0